Precision for All: Diaceutics Manifesto

Commercial Strategy Optimization HCP Engagement & Activation Data & AI Rare / Genetic Disease Oncology & Hematology Pre-launch Launch Post-launch
Sarah Heming
VP of Strategic Marketing at Diaceutics
Brand Strategy
Connect
play
We’re building a future where every eligible patient is found, diagnosed and receives the right therapy at the right time - where precision is not the privilege of the few, but the standard for all.  

 

With newly structured product offerings across our Intelligence and Engagement solutions, Diaceutics is evolving how we help biopharma deliver impact on patient outcomes across the commercialization journey.
 
This is an exciting step towards closing the gap between science and life, underpinned by our vision of Precision for All, unlocking the potential of more than 700 therapies and improving the lives of even more patients.
 
For more than 20 years, Diaceutics has worked at the intersection helping biopharma understand and overcome the barriers that can prevent eligible patients from reaching the right treatment with a successful diagnostic-driven therapy approach.
 
By combining deep industry expertise with real-time intelligence and engagement capabilities, we are uniquely positioned to help pharma activate brands more effectively, accelerate action, and optimise commercial impact. 
 
Watch our short manifesto film below and discover the thinking behind Precision for All.
Discover the new Diaceutics
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network ®
View our solutions
Written By Sarah Heming
Sarah Heming is Interim VP of Strategic Marketing at Diaceutics, where she leads brand strategy and global marketing to help pharma and biotech partners bring diagnostic-driven therapies to more eligible patients. A senior marketing and communications leader with more than two decades across Fortune 500 and highly regulated industries, she has driven transformative growth, award-winning product launches and high-impact corporate rebrands. Sarah previously held marketing leadership roles at Zoetis, Mölnlycke Health Care and Abbott, bringing deep expertise in brand building, stakeholder engagement and omnichannel strategy.
Read more by this author
Commercial Strategy Optimization HCP Engagement & Activation Data & AI Rare / Genetic Disease Oncology & Hematology Pre-launch Launch Post-launch
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.